Clinical Trials on Obstructive Sleep Apnea in Russian Federation
Total 320 results
-
CSL BehringCompletedEmphysema | Alpha1-proteinase Inhibitor DeficiencyAustralia, Russian Federation, United States, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden, Canada, Czech Republic
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Argentina, Germany, Russian Federation, France, Israel, Korea, Republic of, Italy, Poland, Chile, Mexico, Peru, Canada, Hungary, Netherlands, New Zealand
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedAsthma, Bronchial | Bronchial AsthmaRussian Federation, Hungary, Germany, Poland, Bulgaria, Ukraine, Czech Republic
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)France, Germany, United Kingdom, United States, Australia, Austria, Brazil, Hungary, New Zealand, Romania, Russian Federation
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Romania, Russian Federation, Estonia, Peru, Poland, France, Chile, Hungary, Italy, Slovakia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Russian Federation, Taiwan, Canada, Germany, Philippines, South Africa, Spain, United Kingdom, Turkey, Hungary, Guatemala, Australia, Bulgaria, France, Poland, Switzerland, Slovakia, Japan
-
Novartis PharmaceuticalsCompletedAsthmaSouth Africa, Belgium, Croatia, Turkey, Hungary, Colombia, Slovakia, Philippines, Russian Federation, Guatemala, Germany
-
AstraZenecaCompletedBronchial AsthmaGermany, Israel, Brazil, Russian Federation, Argentina
-
AstraZenecaPfizerCompletedAsthmaUnited States, Austria, Croatia, Czech Republic, Finland, France, Greece, Hungary, India, Ireland, Italy, New Zealand, Norway, Pakistan, Philippines, Poland, Portugal, Russian Federation, Singapore, South Africa, Spain, Taiwan, Thai... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Poland, Romania, Russian Federation, Ukraine, Bulgaria, Estonia, Mexico, Korea, Republic of, Slovakia, Greece, China, Italy, Hungary, Czechia
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of, Austria, Belgium, Germany, Greece, Russian Federation, Australia, Brazil, Canada, Denmark, France, Hungary, Israel, Italy, Netherlands, Poland, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Spain, Switzerland, France, Italy, Germany, Turkey, Hungary, Norway, Slovakia, Poland, Russian Federation, Canada, Belgium, Austria, Colombia, Denmark, Finland, Greece, Israel, Mexico, United Kingdom
-
GlaxoSmithKlineCompletedAsthmaArgentina, Russian Federation, United States, Chile, Thailand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Romania, Russian Federation, Ukraine, Argentina, Poland, Czechia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany, Canada, Spain, Russian Federation, United States, Belgium, France, Greece, Sweden, Norway, Turkey, Australia, Netherlands, United Kingdom
-
Glenmark Pharmaceuticals Ltd. IndiaGlenmark Pharmaceuticals S.A.CompletedAsthmaPoland, Czech Republic, India, Russian Federation, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveFrance, Germany, Spain, Russian Federation, Belgium, Ukraine, Philippines, Italy, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Russian Federation, Chile, Poland, Mexico, Estonia, Korea, Republic of, Philippines
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Romania, Italy, Spain, Belgium, Denmark, Estonia, Sweden, Austria, Latvia, United Kingdom, Ukraine, Russian Federation, Greece, Czech Republic, Slovenia, Norway, Lithuania, Slovakia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, France, Greece, Korea, Republic of, New Zealand, Poland, Russian Federation, South Africa, Taiwan, Turkey, Ukraine, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Ukraine, Germany, Peru, Poland, France, Romania, Italy, Mexico
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Poland, Romania, Russian Federation, Ukraine, Taiwan, Bulgaria, South Africa, Korea, Republic of
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Australia, Germany, United Kingdom, China, Philippines, Italy, Chile, Taiwan, Thailand, France, Puerto Rico, Israel, Peru, Colombia, Poland, Brazil, Russian Federation, Romania, Greece
-
GlaxoSmithKlineTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, France, Germany, Poland, Romania, Russian Federation, Spain, United States, Netherlands, Sweden, Korea, Republic of, Canada, United Kingdom, Italy, Mexico
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Canada, Spain, United States, Finland, Italy, Russian Federation, United Kingdom, New Zealand, Australia, France, Greece, Ireland, Netherlands, South Africa
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Estonia, Canada, Chile, Germany, Peru, Philippines, Mexico, Korea, Republic of, Denmark, Russian Federation, Poland, Slovakia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Colombia, Poland, South Africa, Canada, Estonia, Hungary, India, Austria, Israel, Netherlands, United Kingdom, Argentina, France, Italy, Spain, Czech Republic, Denmark, Finland, Greece, Ireland, Mexico, Peru, Phi... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, Belgium, Brazil, Bulgaria, China, Denmark, France, Germany, Greece, Hungary, Italy, Netherlands, New Zealand, Philippines, Poland, Russian Federation, South Africa, Spain, Taiwan, Tunisia, Turkey, Ukraine, United Kingdom
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseBulgaria, China, United States, Argentina, Chile, Czechia, Georgia, Greece, Hungary, India, Israel, Italy, Mexico, Poland, Romania, Russian Federation, Slovakia, Taiwan, Ukraine, United Kingdom, Mauritius
-
SanofiRegeneron PharmaceuticalsRecruitingAsthmaIsrael, Argentina, Chile, Colombia, Kuwait, Lebanon, Mexico, Qatar, Russian Federation, Saudi Arabia, Singapore, United Arab Emirates
-
AstraZenecaCompletedLung Diseases | Pulmonary Disease | COPD | COPD Exacerbation | Respiratory Disorders | Chronic Obstructive Airway Disease | Chronic Obstructive Lung DiseasesUnited States, Argentina, Canada, Chile, Colombia, Italy, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, Serbia, Spain, Taiwan, Thailand, Ukraine
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
Grifols Therapeutics LLCActive, not recruitingPulmonary Emphysema in Alpha-1 PI DeficiencyUnited States, Australia, Denmark, New Zealand, Estonia, Poland, Russian Federation, Sweden, Brazil, Canada, France, Finland
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Colombia, Romania, South Africa, Italy, Hungary, Taiwan, Turkey, Switzerland, Australia, France, Israel, Sweden, China, Thailand, Estonia, Netherlands, Russian Federation, Slovakia, Spain, Argentina, Lithuania, Austria, Cana... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Canada, France, Poland, Russian Federation, Spain, Estonia, Belgium, Peru, Sweden, Greece, Mexico, Norway, Italy, Czechia
-
GlaxoSmithKlineCompletedAsthmaRussian Federation, United States, Peru, Mexico, Netherlands, Poland
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany, Hungary, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Taiwan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Guatemala, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian... and more
-
Novartis PharmaceuticalsSchering-PloughCompletedAsthmaRussian Federation, United Kingdom, Germany, Spain, Czech Republic, Israel, Poland, South Africa, Belgium, Hungary
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, Poland, Belgium, Argentina, Russian Federation, Czechia
-
SanofiRegeneron PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseSpain, Argentina, China, Mexico, Canada, Ukraine, Israel, Italy, Czechia, Korea, Republic of, Bulgaria, Chile, Denmark, Finland, Germany, Hungary, Japan, Poland, Romania, Russian Federation, Slovakia, Sweden, Turkey, United States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Austria, Belgium, Brazil, Canada, China, Colombia, Croatia, Germany, Hungary, India, Ireland, Japan, Norway, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseKorea, Republic of, Turkey, United States, Chile, Czechia, Israel, Russian Federation, Argentina, Brazil, Bulgaria, Canada, Denmark, Estonia, France, Georgia, Germany, Hungary, India, Japan, Latvia, Lithuania, Mexico, Netherlands, Norway and more
-
PfizerCompletedBronchitis, ChronicCanada, United States, Costa Rica, Brazil, Russian Federation, Spain, India, Netherlands, Mexico, Lithuania, Venezuela, Germany, United Kingdom
-
SanofiRegeneron PharmaceuticalsActive, not recruitingChronic Obstructive Pulmonary DiseaseGreece, Belgium, Spain, Argentina, Hungary, South Africa, United Kingdom, France, Latvia, Germany, Netherlands, Russian Federation, Ukraine, United States, Australia, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Lithuania, Me... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, France, Romania, Finland, Taiwan, Bulgaria, Estonia, Canada, Netherlands, Philippines, South Africa, Sweden, Spain, Singapore, Austria, Germany, Latvia, New Zealand, China, Ukraine, Thailand, Greece, United Kingdom and more
-
GlaxoSmithKlineCompletedAsthmaArgentina, Russian Federation, United States, South Africa, Poland, Romania